Everard, A., Matamoros, S., Geurts, L., Delzenne, N. M., & Cani, P. D. (2014). Saccharomyces boulardii Administration Changes Gut Microbiota and Reduces Hepatic Steatosis, Low-Grade Inflammation, and Fat Mass in Obese and Type 2 Diabetic db/db Mice. American Society of Microbiology.

Everard, Amandine, Sébastien Matamoros, Lucie Geurts, Nathalie M. Delzenne, and Patrice D. Cani. Saccharomyces Boulardii Administration Changes Gut Microbiota and Reduces Hepatic Steatosis, Low-Grade Inflammation, and Fat Mass in Obese and Type 2 Diabetic Db/db Mice. American Society of Microbiology, 2014.

Everard, Amandine, et al. Saccharomyces Boulardii Administration Changes Gut Microbiota and Reduces Hepatic Steatosis, Low-Grade Inflammation, and Fat Mass in Obese and Type 2 Diabetic Db/db Mice. American Society of Microbiology, 2014.